Michael Bagdasarian

Title: Michael Bagdasarian: Innovator in Biotechnology

Introduction

Michael Bagdasarian is a notable inventor based in Haslett, MI (US). He has made significant contributions to the field of biotechnology, particularly in vaccine development and enzyme engineering. With a total of 2 patents, his work has the potential to impact various applications in health and industry.

Latest Patents

One of his latest patents is for Chimeric LTB vaccines. This invention involves a chimeric protein formed of a small peptide antigen inserted into an exposed surface region of the B subunit of heat-labile enterotoxin of E. coli. It is designed to serve as an immunogenic vaccine composition. Another significant patent is for glucose isomerases with improved affinity for D-glucose. This genetically engineered glucose isomerase exhibits enhanced affinity for D-glucose, achieved through mutagenizing the gene of a naturally occurring glucose isomerase. The method of preparation involves replacing a larger amino acid in the catalytic site with a smaller one, specifically targeting the Clostridium glucose isomerase sequence.

Career Highlights

Michael has worked with prominent institutions such as Michigan State University and the Michigan Biotechnology Institute. His experience in these organizations has allowed him to develop and refine his innovative ideas in biotechnology.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues, including Chanyong Lee and J Gregory Zeikus. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Michael Bagdasarian's contributions to biotechnology through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in vaccine development and enzyme engineering.